On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure that the company’s clients can continue to develop and produce medicines and vaccines. Among them are several international vaccine manufacturers who have a vaccine candidate against coronavirus in the development stage or already in clinical trials.

The company manufactures consumables and equipment to produce biotech medicines and supplies its customers worldwide with sterile disposable containers, bioreactors, cell culture media and special filters, among other products. Sartorius Stedim Biotech employs over 6,200 people worldwide, more than 1,000 of them in Aubagne.

Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically.